Last Friday, the US Food and Drug Administration (FDA) issued an emergency use license (EUA) to the Tiger Tech COVID Plus Monitor. Innovative wearables use probabilistic machine learning to provide non-diagnostic screening for certain biomarkers that may indicate that an individual is infected. COVID-19. Follow FDA press release, COVID Plus Monitor “is designed for use by trained personnel to help prevent the exposure and spread of SARS-CoV-2, the virus that causes COVID-19.”
Tiger Tech has made a name for itself by developing “wearable sensor systems and research to determine the state of disease”. Novel COVID Plus display A wristband with embedded sensors that receive biometric signals and a small computer processor. It works by identifying biomarkers that can signal the presence of SARS-CoV-2 or other conditions such as cancer or severe allergic reactions. To use the Tiger Tech COVID Plus Monitor, the device is tied to the patient’s left arm, above the elbow. For 3 to 5 minutes, embedded sensors will monitor the patient’s blood flow for vibrating signals. The computer processor then takes the readings and passes them through its probabilistic machine learning model, where the patient’s biomarkers are compared with thousands of other COVID and non-COVID objects. Using this statistical analysis, COVID Plus Monitor determines whether the individual displays any signals indicating biological markers, such as increased blood clotting, in relation to COVID-19. The results of the test are displayed through different colored lights.
The FDA emphasizes that Tiger Tech COVID Plus Monitor is not intended to diagnose SARS-CoV-2 infection. Instead, it is used for people potentially infected without symptoms of COVID-19. In a hospital study, 467 asymptomatic people were enrolled, of which 69 were confirmed positive. The COVID Plus display has successfully determined that 98.6% of COVID-19 positive individuals possess specific biomarkers.
As we said, Tiger Tech COVID Plus Monitor is not a stand-alone solution for diagnosing people infected with SARS-CoV-2. Jeff Shuren, director of the FDA’s Radioactive Health and Equipment Center further explained this, “The incorporation of this new screening device could indicate the presence of some biomarkers. certain, with temperature testing can help identify individuals who may be infected with the virus, thus helping to reduce the spread of COVID-19 in many public settings ”.
This innovative device is part of the US commitment to slow the spread of COVID-19 and, according to Tiger Tech, is “a game changer that will help stop the spread of COVID-19. “.